Back to search

Article

The association of change in serum cholesterol levels and clinical treatment response in patients with schizophrenia: a prospective, randomized and open-label study

2019-08-13

Abstract excerpt

<title>Abstract</title> <p>Background: In the past, it was suggested that dyslipidemia was associated with clinical improvement in patients with schizophrenia treated with antipsychotics; however, measurement at a single time point post-treatment, as done in most studies, could have contributed to the inconsistent results. The aim of this study was to investigate whether changes in serum levels of lipid and other...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf97b419-c947-5bf2-b5f2-686d4c254719
DOI
10.21203/rs.2.12759/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The association of change in serum cholesterol levels and clinical treatment response in patients with schizophrenia: a prospective, randomized and open-label studyDOI 10.21203/rs.2.12759/v1
Association between PLA2 gene polymorphisms and treatment response to antipsychotic medications: A study of antipsychotic-naïve first-episode psychosis patients and nonadherent chronic psychosis patients.Semantic proximity
Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity
Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsSemantic proximity
Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimationSemantic proximity
Association between lipid metabolism and cognitive function in patients with schizophreniaSemantic proximity
Atypical antipsychotic (AAP)-induced metabolic toxicity : study of mechanisms, biomarkers and reversal strategiesSemantic proximity
Guideline Adherence for Cardiometabolic Monitoring of Patients Prescribed Antipsychotic Medications in UK primary care: A Retrospective Observational studySemantic proximity
Does Sex affect Antipsychotic Associated Weight Gain in Patients Being Treated for Psychotic Disorders: A Protocol for a Systematic ReviewSemantic proximity
Long-term Metabolic Side Effects of Second-Generation Antipsychotics in Chinese Patients with Schizophrenia: A Within-Subject Approach with modelling of dosage effectsSemantic proximity
Antipsychotic management in general practice: serial cross-sectional study (2011-2020)Semantic proximity
Antipsychotic drugs increase Neuregulin1b1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptomsSemantic proximity
Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: A trial designSemantic proximity
Select a neighboring publication to make it the new centre.